A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation
- PMID: 1609773
- DOI: 10.1002/ajh.2830400307
A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation
Abstract
We have identified a patient with von Willebrand's disease (vWD) resembling type IIB vWD, with increased ristocetin induced platelet aggregation (RIPA), the absence of the large multimers of von Willebrand factor (vWF) in plasma, and the presence of the large multimers in platelets in whom a family study indicated a probable double heterozygous inheritance pattern. The propositus was a 12-year-old boy with frequent epistaxis and bruising. Abnormal hemostatic findings included a prolonged bleeding time (BT), decreased levels of factor VIII coagulant activity (VIIIC), von Willebrand factor antigen (vWF:Ag), ristocetin cofactor (RCof), and an increased RIPA. In the presence of ristocetin, binding of the patient's plasma vWF to normal platelets was increased but binding of normal vWF to his platelets was normal. SDS-agarose gel (1.5%) electrophoresis revealed that plasma vWF lacked the large multimers, and 3.0% gel electrophoresis revealed that the multimers had a 5-band pattern similar to normal. The above findings were consistent with type IIB vWD, but 1-deamino[8-D-arginine]-vasopressin (DDAVP) infusion resulted in a shortened BT and the transient appearance of large multimers without a decrease in the platelet count. Family studies revealed that his mother has mild bleeding symptoms, decreased VIIIC, vWF:Ag, and RCof levels and normal to slightly reduced RIPA with a multimer pattern consistent with type I vWD. In contrast, the father, sister, and paternal grandfather were asymptomatic, with a slightly decreased VIIIC level but a normal BT and vWF:Ag and RCof levels. Their RIPA and vWF binding to normal platelets were increased, but unlike the propositus their plasma contained large multimers. We concluded that the propositus is a type IIB-like variant differing from previously reported IIB variants in two ways: 1) his response to DDAVP and 2) a possible double heterozygous mode of inheritance rather than the usual dominant route.
Similar articles
-
A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.Blood. 1986 Jul;68(1):149-56. Blood. 1986. PMID: 3487353
-
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814. Semin Thromb Hemost. 2002. PMID: 11992235 Clinical Trial.
-
Laboratory diagnosis and molecular classification of von Willebrand disease.Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506352 Review.
-
von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma.Blood. 1986 Sep;68(3):668-72. Blood. 1986. PMID: 3488775
-
Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.Semin Thromb Hemost. 2005 Nov;31(5):577-601. doi: 10.1055/s-2005-922230. Semin Thromb Hemost. 2005. PMID: 16276467 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous